Method of Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,750,715 | Method of Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification In force · High confidence UsedRemaining | Panion & BF Biotech Inc. | In force | High confidence | ||
| US 9,889,113 | Method for Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification Lapsed Feb 13, 2026 on the fee record Medium confidence | Panion & BF Biotech, Inc. | Lapsed Feb 13, 2026 on the fee record | Medium confidence | ||
| Application 15/894,544 | Method for Reversing, Preventing, Delaying or Stabilizing Soft Tissue Calcification Abandoned Abandoned Mar 20, 2019 | Panion & BF Biotech, Inc. | Abandoned | Abandoned Mar 20, 2019 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Panion & BF Biotech Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.